NIH-funded research R01 grant

Understanding how genetic differences affect sensitivity to ultra-potent synthetic opioids in mice

Official title: Genetic Variation of Ultra-Potent Synthetic Opioid Sensitivity in Mice

Funded at Jackson Laboratory · NIH-11079610 · Data updated 2026-11-12

This study is looking at how different genes in mice affect their reactions to strong synthetic opioids like fentanyl, with the hope of discovering new ways to help people who overdose on these drugs.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJackson Laboratory
NIH-funded
Lab location1 site (Bar Harbor, United States)
Project startJuly 1, 2023
Project endApril 30, 2026
Funding year2025
Award (this year)$443,446
NIH project number5R01DA059060-03
Project IDNIH-11079610 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research would include individuals at risk of opioid overdose, particularly those using ultra-potent synthetic opioids.

Less likely to help

Patients who do not use opioids or are not at risk of opioid overdose may not receive any benefit from this research.

What this research studies

This research investigates the genetic factors that influence how different mice respond to ultra-potent synthetic opioids, such as fentanyl. By using genetically diverse mouse models, the study aims to identify specific genes that may contribute to variations in opioid toxicity. The researchers will employ advanced techniques like CRISPR gene editing and respiratory monitoring to assess how these genetic differences affect the mice's response to opioid exposure. The ultimate goal is to find new ways to reverse the effects of opioid overdoses, particularly for those opioids that current treatments do not effectively address.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective treatments for opioid overdoses, potentially saving lives.

How similar studies have gone: While the approach of using genetic models to study opioid sensitivity is established, the specific focus on ultra-potent synthetic opioids represents a novel area of investigation.

Where this research is happening

  • Jackson Laboratory
    Bar Harbor, United States
    Active

Researchers

  • Principal investigator: Bubier, Jason a — Jackson Laboratory
  • Study coordinator: Bubier, Jason a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.